GNT Pharma’s GedaCure® Approved for the Treatment of Dogs With Cognitive Dysfunction Syndrome
New drug showing symptomatic relief and disease-modifying potential in canine cognitive dysfunction syndrome YONGIN, South Korea--(BUSINESS WIRE)--#AlzheimersDisease--GNT Pharma today...






